Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1KRKA, d.d., Novo mesto Novo mesto SI

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-270 - Rev 04 of Krka, D.d., Novo Mesto Novo Mesto Si

Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-270 - Rev 04 of Krka, D.d., Novo Mesto Novo Mesto Si 1

20

Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Norfloxacin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2000-270 - Rev 04

This Chemical Type CEP, issued on March 14, 2013, remains in force until January 26, 2021, ensuring its reliability within the pharmaceutical industry.

Substance Number 1248 associated with this CEP further emphasizes